Page last updated: 2024-08-23

epirubicin and Cardiovascular Diseases

epirubicin has been researched along with Cardiovascular Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's2 (20.00)18.2507
2000's4 (40.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, X; Jing, T; Sun, Y; Wang, F; Xu, C; Zhang, C1
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S1
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S1
Di Mauro, M; Ficorella, C; Fratini, S; Mancini, M; Penco, M; Procaccini, V; Ricevuto, E; Romano, S; Stifano, G1
Bighin, C; Del Mastro, L; Lunardi, G; Schettini, G; Stevani, I; Vannozzi, MO; Venturini, M1
Seiter, K1
Bria, E; Calabretta, F; Carpino, A; Cognetti, F; Cuppone, F; Ferretti, G; Nisticò, C; Sperduti, I; Terzoli, E; Toglia, G; Tomao, S; Vitelli, G1
Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M1
Brynjolf, I; Dombernowsky, P; Fogh, J; Hansen, M; Havsteen, H; Jensen, JB; Munck, O; Nielsen, D1
Maciejewicz, J; Pawlicki, M; Zuchowska-Vogelgesang, B1

Reviews

2 review(s) available for epirubicin and Cardiovascular Diseases

ArticleYear
Chemotherapy plus estramustine for management of castration-resistant prostate cancer: meta-analysis of randomized controlled trials.
    Actas urologicas espanolas, 2014, Volume: 38, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Combined Modality Therapy; Docetaxel; Epirubicin; Epothilones; Estramustine; Fatigue; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Orchiectomy; Paclitaxel; Peripheral Nervous System Diseases; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine

2014
Toxicity of the topoisomerase II inhibitors.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:2

    Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases

2005

Trials

4 trial(s) available for epirubicin and Cardiovascular Diseases

ArticleYear
Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasm Staging; Probability; Prospective Studies; Receptor, ErbB-2; Risk Assessment; Soft Tissue Neoplasms; Statistics, Nonparametric; Survival Rate; Trastuzumab; Treatment Outcome

2003
Troponin-T and myoglobin plus echocardiographic evaluation for monitoring early cardiotoxicity of weekly epirubicin-paclitaxel in metastatic breast cancer patients.
    Anti-cancer drugs, 2007, Volume: 18, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiovascular Diseases; Echocardiography; Epirubicin; Female; Genes, erbB-2; Humans; Middle Aged; Monitoring, Physiologic; Myoglobin; Paclitaxel; Stroke Volume; Troponin T

2007
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome

1997
[Clinical trial of epirubicin in patients with cardiologic contraindications for the use of doxorubicin].
    Przeglad lekarski, 1987, Volume: 44, Issue:4

    Topics: Adult; Aged; Cardiovascular Diseases; Clinical Trials as Topic; Doxorubicin; Epirubicin; Female; Humans; Male; Middle Aged; Neoplasms

1987

Other Studies

4 other study(ies) available for epirubicin and Cardiovascular Diseases

ArticleYear
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Anticancer research, 2009, Volume: 29, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult

2009
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Anticancer research, 2010, Volume: 30, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult

2010
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.
    British journal of cancer, 2011, Nov-22, Volume: 105, Issue:11

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cardiovascular Diseases; Cyclophosphamide; Docetaxel; Doxorubicin; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Taxoids; Troponin I; Ventricular Function, Left

2011
Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:11

    Topics: Adult; Aged; Breast Neoplasms; Cardiovascular Diseases; Epirubicin; Female; Humans; Middle Aged; Stroke Volume

1990